Pharmacist providers will fill gaps in healthcare, control costs

May 10, 2015

When pharmacists achieve provider status, patients will benefit, payers will save on costs, and providers will get an assist. So what's holding things up?

Robert MabeeWhile extending Medicaid to an additional 3% of Americans, the Affordable Care Act (ACA) will create significant gaps in care for the average taxpayer, not only in coverage but in the availability of provider services as well. This new environment creates an opportunity for pharmacists to deliver provider services that benefit average taxpayers and their payers. This system will be more efficient and save money for patients (exempted elites not included). But this opportunity won’t just happen.

Provider status will enable pharmacists to give basic care for UTIs, headaches, simple rashes, etc. While providing accessible care at a much lower cost, pharmacists can manage and treat minor problems and triage the more complicated issues to primary care physicians or acute-care facilities. This role of providing triage to patients is as old as the profession of pharmacy.

Under the ACA, there is growing realization that treatment options and costs must be limited or capped. The only way to do that without injuring patients is to have pharmacists perform medication therapy management (MTM) and consult patients on their options and the benefits of managing their medications, while ensuring compliance with their clinical goals.

By virtue of their profession and training, pharmacists are thoroughly prepared to help patients. To do so, they must have provider status.

See also: Retail pharmacy returns to primary care

The pharmacist's POV

The problems of polypharmacy have been discussed extensively in textbooks and articles. From the point of view of a corporate manager, however, a pharmacist’s efforts to limit a patient’s obsession with taking just one more medication should result in discipline or dismissal of the pharmacist.

When success is measured by quarterly increases in dollar volume, polypharmacy, overutilization, and even addiction are rarely viewed as problems. In fact, all such negative behavior by or “on behalf” of patients has been routinely encouraged. The corporate paradigm encourages dispensing in larger quantities and labels the polypharmacy patient a VIP.

MTM signifies a return to a traditional approach to pharmacy services. When patients were paying for their prescriptions, pharmacists routinely reviewed issues of care with each patient in an attempt to streamline therapy and reduce costs. The advent of third-party payers changed the relationship, and patients began to view themselves as beneficiaries and not as consumers.

See also: The pharmacist's role in a changing healthcare landscape

Other providers did it

Years ago, most pharmacists were self-employed, and their incomes were similar to those of certified registered nurse anesthetists (CRNAs). Today, pharmacists are mostly employees, and their salaries are significantly below the incomes of CRNAs, many of whom are still self-employed.

More than 20 years ago, there was a battle to grant CRNAs provider status. For years they had been reimbursed as employees of MD anesthesiologists, who took the entire fee and then paid the CRNAs as employees with a production clause in their employment contracts.

Eventually, the CRNAs decided to band together and hire lawyers to seek “provider status” with major carriers, Medicaid, and Medicare. These goals were reached, in most instances, when we pursued this status on a state-by-state basis. (I was a lawyer hired to represent several groups of CRNAs.)

It didn’t just happen. It required an investment and some expense, but the results were well worth the effort.

 

No more Rodney Dangerfield

Provider status for pharmacists will bring savings for patients and will increase the value of pharmacists to the system and their employers.

The change will lead to the restructuring of many corporate pharmacies that had viewed pharmacists as “expensive” employees. Under the new system, pharmacists will again be viewed as valuable assets. Instead of limiting the number of pharmacists on the payroll, companies that want to increase productivity, services, and revenue will seek to hire more pharmacists.

Don’t be deceived. There is opportunity for failure. Pharmacists cannot sit on their hands and wait for a professional association or their employers to get the job done.

In this new environment, pharmacists are the canaries in the coalmine. What we do to obtain and enhance our status as providers will have a profound effect on our profession.

Our achievement of provider status will quickly help resolve the dwindling supply of available services. It will also be a wake-up call for all primary care providers.

Robert L. Mabee is a pharmacist and attorney practicing in Sioux Falls, S.D. He also holds an MBA. Contact him at rlmabee@mabeelaw.com.

x